Excalibur Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Excalibur Management's LLY Position: Q1 2026 in Review
Excalibur Management increased its Eli Lilly (LLY) stake by 4.9% in Q1 2026, buying an estimated $66.9K and bringing the position to 1,408 shares worth $1.29M. The position accounts for 0.46% of the portfolio, ranked #63.
Excalibur Management first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.44M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Excalibur Management held 1,408 shares of Eli Lilly worth $1.29M as of Q1 2026.
- Excalibur Management bought 66 Eli Lilly shares in Q1 2026, an estimated $66.9K.
- Eli Lilly made up 0.46% of Excalibur Management's portfolio in Q1 2026, its #63 holding.
- Excalibur Management first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
- Excalibur Management's Eli Lilly position peaked at $1.44M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.